Author:
Harth Stefan,Frisch Christian
Reference24 articles.
1. Kaplon H, Muralidharan M, Schneider Z, Reichert JM (2020) Antibodies to watch in 2020. MAbs 12(1):1703531. https://doi.org/10.1080/19420862.2019.1703531
2. Therapeutic monoclonal antibodies approved or in review in the EU or the US. (2020). https://www.antibodysociety.org/resources/approved-antibodies/. Accessed February 8 2020
3. Mok CC, van der Kleij D, Wolbink GJ (2013) Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFalpha biologics in rheumatic diseases. Clin Rheumatol 32(10):1429–1435. https://doi.org/10.1007/s10067-013-2336-x
4. Mazor Y, Almog R, Kopylov U, Ben Hur D, Blatt A, Dahan A, Waterman M, Ben-Horin S, Chowers Y (2014) Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease. Aliment Pharmacol Ther 40(6):620–628. https://doi.org/10.1111/apt.12869
5. Page N, Murray N, Perruisseau G, Steck AJ (1985) A monoclonal anti-idiotypic antibody against a human monoclonal IgM with specificity for myelin-associated glycoprotein. J Immunol 134(5):3094–3099
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献